stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Shares outstanding
AtriCure, Inc.'s shares outstanding at the end of fiscal 2025 was $47.8M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $49.8M. Over the past ten years it has ranged from $28.1M (fiscal 2015) to $47.8M (fiscal 2025) — the current reading is the highest in ten years. AtriCure, Inc. ranks 29th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $47.8M | 1.67% |
| FY2024 | $47.0M | 1.42% |
| FY2023 | $46.3M | 1.24% |
| FY2022 | $45.7M | (0.65%) |
| FY2021 | $46.0M | 9.29% |
| FY2020 | $42.1M | 12.07% |
| FY2019 | $37.6M | 10.27% |
| FY2018 | $34.1M | 5.25% |
| FY2017 | $32.4M | 2.46% |
| FY2016 | $31.6M | 12.66% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $49.8M | 1.97% |
| Jun 2026 | $48.9M | (0.36%) |
| Mar 2026 | $49.0M | 2.71% |
| Dec 2025 | $47.8M | (0.35%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MMED MiniMed Group, Inc. compare | $281.0M |
| STVN Stevanato Group S.p.A. compare | $273.1M |
| XRAY DENTSPLY SIRONA Inc. compare | $199.2M |
| NVST Envista Holdings Corporation compare | $163.4M |
| WRBY Warby Parker Inc. compare | $126.1M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| ATRC AtriCure, Inc. | $49.8M |
| ICUI ICU Medical, Inc. compare | $25.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement